Tirzepatide 12.5 mg: what it costs
Step 5 of the tirzepatide ladder, around weeks 17-20. 6 providers charge the same here as at the starting dose — the rest may not.
Updated 2026-09-18 · every price checked by hand
12.5 mg is where a lot of programmes quietly start charging you more, and almost nobody warns you before you sign up.
12.5 mg is step 5 of 6 on the tirzepatide ladder, reached around weeks 17-20. A step between the two studied doses, used where 10 mg has been tolerated but has stopped producing change.
Because this is an early rung, the main cost question is not what 12.5 mg costs today but what happens when you reach the higher doses. Programmes that hold one price across the whole ladder are the ones that make that predictable.
The rung where the bill changes
Dose-tiered pricing means your cost rises as the treatment starts working. We track which programmes hold a single price across the whole ladder and which do not, because over a full titration that is worth more than any advertised discount.
What 12.5 mg is for
12.5 mg is the least necessary rung on the ladder for most people. It exists for the case where 10 mg was tolerated well but has stopped producing change, and you want one more step before the maximum. Reaching it should be a deliberate clinical decision rather than the automatic next entry in a schedule — and a programme that escalates you here without asking how you are doing is telling you something about how it operates.
Escalating this far is a clinical decision rather than a default. Plenty of people never need it.
What 12.5 mg costs
6 of the providers we track hold a single price at every dose, so 12.5 mg costs the same as the starting dose. They are listed first below because at this rung that is the whole ballgame.
| Provider | Price at 12.5 mg | Per year | Score |
|---|---|---|---|
| Coreage Rx | $199 | $2,388 | 4.5 |
| Trimi | $125 | $1,500 | 4.6 |
| PlexusDx | $189 | $2,268 | 4.4 |
| Mochi Health | $278 | $3,336 | 3.6 |
| Eden | $298 | $3,576 | 3.1 |
| Remedy Meds | $399 | $4,788 | 3.5 |
Cheapest flat-rate option at 12.5 mg: Trimi at $125 a month, which is what it charges at every other rung too.
The remaining 14 providers either price by dose or do not publish a flat-rate commitment. Their quoted figures start at $125 a month, but that is the starting-dose price — ask specifically what 12.5 mg will cost before you assume it holds.
The question to ask before you start. "What will I be charged when I reach 12.5 mg?" If the answer is not the same number you were quoted at the start, you are on a tiered programme and should budget for the higher figure rather than the advertised one.
Do you need to go higher than 12.5 mg?
Not necessarily. The ladder exists so that you can stop where the medication is working for you, and plenty of people settle below the maximum. Reaching the top dose is not a measure of success, and the trial figures are averages rather than targets.
Should I go from 10 mg straight to 15 mg?
That is a question for your prescriber, but the ladder exists precisely to avoid large jumps. 12.5 mg is there to make the last step gentler, and skipping it is how the final increase becomes unpleasant.
Before you spend anything: approved oral GLP-1s start at $149 a month and Medicare drops to $50 in July 2026. Both undercut a large part of this market, and neither is compounded.
Read next
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure